| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.043 | 0.3 |